Abstract
Diabetic kidney disease (DKD) is one of the common microvascular complications of diabetes mellitus and is the leading cause of end-stage renal disease (ESRD). Lysophosphatidic acid/lysophosphatidic acid receptor 1 (LPA/LPA1) signaling pathway mediates a series of pathological processes by triggering downstream signaling cascade and is an important regulatory pathway for many diseases. In terms of DKD, LPA/LPA1 signaling pathway may play a role in mesangial cell proliferation, fibrosis, podocyte injury, inflammation and oxidative stress to promote the progression of DKD. However, there are limited reports on the specific molecular mechanism of this pathway in the pathogenesis of DKD. In-depth study of the role of LPA/LPA1 signaling pathway is of great significance for the diagnosis and treatment of DKD. Key words: Lysophosphatidic acid; Signaling pathway; Diabetic kidney disease
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
